B. Oeksuezoglu Et Al. , "Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes," CHEMOTHERAPY , vol.54, no.5, pp.352-356, 2008
Oeksuezoglu, B. Et Al. 2008. Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes. CHEMOTHERAPY , vol.54, no.5 , 352-356.
Oeksuezoglu, B., Abali, H., Hayran, M., Yildirim, N., Budakoglu, B., & Zengin, N., (2008). Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes. CHEMOTHERAPY , vol.54, no.5, 352-356.
Oeksuezoglu, Berna Et Al. "Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes," CHEMOTHERAPY , vol.54, no.5, 352-356, 2008
Oeksuezoglu, Berna Et Al. "Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes." CHEMOTHERAPY , vol.54, no.5, pp.352-356, 2008
Oeksuezoglu, B. Et Al. (2008) . "Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes." CHEMOTHERAPY , vol.54, no.5, pp.352-356.
@article{article, author={Berna Oeksuezoglu Et Al. }, title={Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes}, journal={CHEMOTHERAPY}, year=2008, pages={352-356} }